http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-145705-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_522802f05c43c31180440718cd8fbf79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_762950aea9d457ae912d0416e73d83f0
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21
filingDate 1979-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd0f51c1163937d44c14c9b9bd35a8b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bba35873d0eef7403ca8fb82e91305a0
publicationDate 1981-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-145705-A1
titleOfInvention METHOD OF GENERATING ORGAN SPECIFIC RETROVIRUS IMMUNE PREVENTION AGENTS FOR PROPHYLAXIS, THERAPY AND DIAGNOSTICS
abstract The preparation method of organ-specific retrovirus immuno-preparations for prophylaxis, therapy and diagnostics is applicable in the field of human medicine and is characterized in that contained in affected organs and tissues or their tum ble retroviruses are enriched and purified directly or after the interposition of cell culture passages and that the effective , but harmless or inactivated viral components can be used as an organ-specific prophylactic, therapeutic or diagnostic agent for specific serological and organ-specific diagnostics of cell-mediated immune reactions in retrovirus-related infections (tumors) in humans.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6110468-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6855315-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6241990-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6982160-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9944902-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8546124-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5846805-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2682966-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2686097-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5677429-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6498008-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9306211-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5840563-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5597721-A
priorityDate 1979-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449702218
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86726269

Total number of triples: 29.